My Account Log in

2 options

Medication for the treatment of alcohol use disorder : a brief guide.

Online

Available online

View online

U.S. Government Documents Available online

View online
Format:
Book
Government document
Contributor:
Center for Substance Abuse Treatment (U.S.). Division of Pharmacologic Therapies, issuing body.
JBS International (Firm)
Series:
DHHS publication ; no. (SMA) 15-4907.
HHS publication ; no. (SMA) 15-4907
Language:
English
Subjects (All):
Alcoholism--Treatment.
Alcoholism.
Alcohol-Related Disorders--drug therapy.
Disulfiram--therapeutic use.
Naltrexone--therapeutic use.
Taurine--therapeutic use.
Medical Subjects:
Alcohol-Related Disorders--drug therapy.
Disulfiram--therapeutic use.
Naltrexone--therapeutic use.
Taurine--therapeutic use.
Genre:
Government publications -- United States.
Online resources.
Physical Description:
1 online resource (ii, 34 pages).
Place of Publication:
Rockville, MD : U.S. Department of Health and Human Services Substance Abuse and Mental Health Services Administration, Center for Substance Abuse Treatment, Division of Pharmacologic Therapies, 2015.
Summary:
Medication-assisted treatment has shown much promise in reducing alcohol use and promoting abstinence in patients diagnosed with alcohol use disorder. Considerable research evidence and consensus among experts support the use of pharmacologic treatments in primary care settings. A number of FDA-approved medications have been shown to be important elements of such treatment. Although some patients do not benefit from medication-assisted treatment, most do. For each patient deemed an appropriate candidate for medication-assisted treatment, multiple pharmacologic agents offer a variety of options so that treatment can be tailored to each patient's needs and circumstances. As a new patient care models are encouraged by the Patient Protection and Affordable Care Act and the accompanying improvements in the quality and quantity of treatment options that are anticipated as the ACA is implemented, there is considerable potential for expanding the use of medication-assisted treatment as clinicians recognize their safety, efficacy, and cost-effectiveness.
Notes:
Includes bibliographical references.
Online resource, PDF version; title from title page (SAMHSA, viewed Mar. 9, 2018).
OCLC:
932048733
Access Restriction:
No restrictions on access.

The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.

Find

Home Release notes

My Account

Shelf Request an item Bookmarks Fines and fees Settings

Guides

Using the Find catalog Using Articles+ Using your account